LOWELL, Mass., May 22, 2018 /PRNewswire/ -- Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the successful ...

Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the ...

98% of placements using SOLOPASS® 2.0 entered the ventricular system, versus only 10% of freehand placements. 86% of placements using SOLOPASS® 2.0 accurately reached the ipsilateral frontal horn ...

Please provide your email address to receive an email when new articles are posted on . The FDA and Medtronic alerted health care providers to no longer implant patients with end-stage HF with a ...

With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.

SAN RAMON, Calif.--(BUSINESS WIRE)--BioVentrix, Inc., developer of the first transcatheter device for left ventricular remodeling after a heart attack, today announced it received renewal of the ...

BLUE BELL, Pa., November 18, 2025--(BUSINESS WIRE)--inTRAvent Medical Partners LP, a pioneer in bedside, image-guided neurosurgical innovation, today announced the publication of a peer-reviewed study ...